Clinical Trial: Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

---

Official Title: Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men

Brief Summary: The purpose of this study is to determine the safety and efficacy of an oral testosterone undecanoate formulation for use as testosterone-replacement therapy in men with low testosterone.